Atlas Trials

Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention

Clinical trial NCT04778787 · COMPLETED

Trial details

NCT number
NCT04778787
Sponsor
I.M. Sechenov First Moscow State Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Congestive Heart Failure
Start date
2021-01-01
Primary completion
2022-08-01
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.